SARS-CoV-2 seroprevalence Schleswig-Holstein

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030604

Enrollment

9000

Registered

2022-10-24

Start date

2022-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID19

Interventions

Group 1: cohort of the population with questionnaire and antibody test for the S1 domain

Eligibility

Sex/Gender

All

Age

5 Years to 85 Years

Inclusion criteria

Inclusion criteria: living in Schleswig-Holstein

Exclusion criteria

Exclusion criteria: not living in Schlewsig-Holstein

Design outcomes

Primary

Measure	Time frame
How many people incl. children in Schleswig-Holstein are posivitve with SARS-CoV-2 S1 antibodies?	—

Secondary

Measure	Time frame
How do antibody titers differ regarding age, gender, comorbidities, vaccination, infection and living conditions? Would it be possible to infer recommendations of action to protect specific groups of the population for the next fall/winter season?	—

Countries

Germany

Contacts

Public ContactNadja Käding

Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Infektiologie und Mikrobiologie

nadja.kaeding@uksh.de045150045300

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026